Medicare Advantage Prescription Drug Contracting (MAPD)
Guidance for information of particular importance to Part D plan sponsors including Part D application requirements, payment issues, marketing guidelines, formulary requirements, coordination of benefits, plan reporting and oversight, and claims processing.
Final
Issued by: Centers for Medicare & Medicaid Services (CMS)
Issue Date: July 30, 2020
CMS has provided specific information of particular importance to Part D plan sponsors. Included are links to sub pages with more detailed information on areas such as Part D application requirements, payment issues, marketing guidelines, formulary requirements, coordination of benefits, plan reporting and oversight, claims processing, and other special guidance.
Click the section that best matches your information needs. Please check back, as we will continue to update these resources regularly.
HHS is committed to making its websites and documents accessible to the widest possible audience, including individuals with disabilities. We are in the process of retroactively making some documents accessible. If you need assistance accessing an accessible version of this document, please reach out to the guidance@hhs.gov.
DISCLAIMER: The contents of this database lack the force and effect of law, except as authorized by law (including Medicare Advantage Rate Announcements and Advance Notices) or as specifically incorporated into a contract. The Department may not cite, use, or rely on any guidance that is not posted on the guidance repository, except to establish historical facts.